Phase 1 Hepatitis B Virus Related Hepatocellular Carcinoma Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

A Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma

Hepatitis B Virus Related Hepatocellular CarcinomaHepatocellular Carcinoma Recurrent

SCG Cell Therapy Pte. Ltd.46 enrolled6 locationsNCT05417932

Recruiting

Phase 1

A Study of SCG101 TCR-T Cell Therpay in the Treatment of Subjects With Hepatitis B Virus-Related

Hepatocellular CarcinomaHCCHepatitis B Virus Related Hepatocellular Carcinoma

SCG Cell Therapy Pte. Ltd.38 enrolled7 locationsNCT06617000